Abbott Laboratories Quote, Financials, Valuation and Earnings

Abbott Laboratories Price Quote

+0.26 (+0.26%)
(Updated: March 22, 2023 at 12:40 PM ET)

Abbott Laboratories Key Stats

Abbott Laboratories (ABT) is a Sell

Day range:
$97.29 - $98.41
52-week range:
$93.25 - $124.36
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Abbott Laboratories Make?

Is Abbott Laboratories Growing As A Company?

  • What Is Abbott Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.12%
  • What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.47%

Abbott Laboratories Stock Price Performance

What Is Abbott Laboratories 52-Week High & Low?

Abbott Laboratories Price To Free Cash Flow

Is It Risky To Buy Abbott Laboratories?

Is Abbott Laboratories Cash Flow Positive?

  • What Is ABT Cash Flow From Operations?
    Cash flow from operations (TTM) is $9.6B
  • What Is Abbott Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$7.6B
  • What Is Abbott Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.7B

Abbott Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    ABT return on invested capital is 13.02%
  • What Is Abbott Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 9.35%
  • What Is ABT Return On Equity?
    ROE is a measure of profitability and is 19.25%

Abbott Laboratories Earnings Date & Stock Price

Abbott Laboratories Competitors

  • Who Are Abbott Laboratories's Competitors?
    Below is a list of companies who compete with Abbott Laboratories or are related in some way:
    • Baxter International Inc (BAX)
    • Becton, Dickinson and Co (BDX)
    • Cardiovascular Systems Inc (CSII)
    • Intuitive Surgical Inc (ISRG)
    • ShockWave Medical Inc (SWAV)

Abbott Laboratories Dividend Yield

Abbott Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: -46.85% 10.64%
Revenue: -12.01% 3.96%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 121.44
Upside from Last Price: 23.51%

Major Shareholders

  • How many ABT shares are owned by institutional investors?
    2.1B ABT shares are owned by institutional investors
  • How many ABT shares are owned by insiders?
    15.3M ABT shares are owned by insiders